The Development of the Bradykinin Agonist Labradimil as a Means to Increase the Permeability of the Blood-Brain Barrier
- 1 January 2001
- journal article
- review article
- Published by Springer Science and Business Media LLC in Clinical Pharmacokinetics
- Vol. 40 (2), 105-123
- https://doi.org/10.2165/00003088-200140020-00003
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Evidence that Cereport's Ability to Increase Permeability of Rat Gliomas Is Dependent Upon Extent of Tumor Growth: Implications for Treating Newly Emerging Tumor ColoniesExperimental Neurology, 2000
- RMP-7CNS Drugs, 1997
- Unlocking the Blood–Brain Barrier: A Role for RMP-7 in Brain Tumor TherapyExperimental Neurology, 1996
- Bradykinin Selectively Opens Blood-Tumor Barrier in Experimental Brain TumorsJournal of Cerebral Blood Flow & Metabolism, 1994
- Bradykinin and inflammatory painTrends in Neurosciences, 1993
- Cloning and pharmacological characterization of a human bradykinin (BK-2) receptorBiochemical and Biophysical Research Communications, 1992
- Bradykinin Receptors of Cerebral Microvessels Stimulate Phosphoinositide TurnoverJournal of Cerebral Blood Flow & Metabolism, 1991
- Structure-activity studies of bradykinin and related peptides. B2-receptor antagonists.Hypertension, 1991
- The Effect of Cellular Microenvironment on Vessels in the Brain. Part 1: Vessel Structure in Tumour, Peritumour and Brain from Humans with Malignant GliomaInternational Journal of Radiation Biology, 1991
- New selective agonists for neurokinin receptors: pharmacological tools for receptor characterizationTrends in Pharmacological Sciences, 1988